Rare diseases
Investigational molecules
Locations
Batiment Bioserra, 60 Avenue Rockefeller, 69008 Lyon, France
Phaxiam Therapeutics focuses on hip and knee prosthetic joint infection linked to Staphylococcus aureus, with particular interest in cases managed with DAIR and suppressive antibiotic therapy. Its research activity includes clinical evaluation of bacteriophage therapy alongside standard infection management.
The sponsor’s work in this area is centered on difficult-to-treat joint infections where implant preservation remains clinically important.
Phaxiam Therapeutics runs clinical trials in conditions such as Medical device site joint infection, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
